Penbutolol patient counseling information: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
ShiSheng (talk | contribs)
nocaptcha
8,707 edits
Created page with "__NOTOC__ {{Penbutolol}} {{CMG}}; {{AE}} {{SS}} ==Patient Counseling Information== Patients, especially those with evidence of coronary artery insufficiency, should be warne..."
 
GeraldChi (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
8,887 edits
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Penbutolol#Patient Counseling Information]]
{{Penbutolol}}
{{CMG}}; {{AE}} {{SS}}
 
==Patient Counseling Information==
 
Patients, especially those with evidence of coronary artery insufficiency, should be warned against interruption or discontinuation of levatol® without the physician’s advice. Although cardiac failure rarely occurs in properly selected patients, those being treated with ß-adrenergic receptor antagonists should be advised of the symptoms of heart failure and to report such symptoms immediately, should they develop.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LEVATOL (PENBUTOLOL SULFATE) TABLET [ACTIENT PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d241fc80-2c55-4dbb-bdb2-44f731afa137 | publisher =  | date =  | accessdate = 4 February 2014 }}</ref>
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Beta blockers]]
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 00:01, 22 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Penbutolol_patient_counseling_information&oldid=997847"